Skip to content

Clinical trials

Phase 3 Carcinoma, Non-Small-Cell Lung trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Phase: Phase 3 Country / region: Netherlands Clear all

130 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20043
20054
20066
20074
20085
20094
20103
20112
20122
20134
20144
20158
20167
20171
20183
20196
202011
20218
20225
20239
202410
202510
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed52
Active, not recruiting30
Recruiting27
Terminated20
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca11
Hoffmann-La Roche11
Eli Lilly and Company10
Bristol-Myers Squibb8
Merck Sharp & Dohme LLC8
Pfizer8
Novartis Pharmaceuticals7
Boehringer Ingelheim5
GlaxoSmithKline5
Daiichi Sankyo4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung130
Lung Neoplasms25
Neoplasm Metastasis11
Neoplasms8
Carcinoma7
Lung Diseases5
Adenocarcinoma3
Adenocarcinoma of Lung3
Carcinoma, Bronchogenic2
Carcinoma, Large Cell2

Trials

Showing 1 to 25 of 130. Each trial links to its page on Pharma Observatory.

30 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.